Literature DB >> 11275384

Analgesic effect of bisphosphonates in mice.

A Bonabello1, M R Galmozzi, T Bruzzese, G P Zara.   

Abstract

Bisphosphonates are analogues of inorganic pyrophosphate and are inhibitors of bone resorption. Many derivatives have been developed for the treatment of enhanced bone resorption; several reports reveal that treatment with bisphosphonates is able to reduce the pain associated with different painful diseases. This study tested the antinociceptive action of four bisphosphonates, clodronate, alendronate, pamidronate and etidronate, in comparison with that of morphine and acetylsalicylic acid using two algesimetric tests in mice, tail-flick and writhing tests. In the tail-flick test, after intravenous (i.v.) injection, a dose-dependent antinociception was present after pamidronate, clodronate and acetylsalicylic acid whereas etidronate and alendronate produced an analgesic effect only with the highest dose tested. We also studied the central effect of clodronate and pamidronate and, after intracerebroventricular injection, both bisphosphonates showed a dose-dependent antinociceptive effect. In the writhing test clodronate and pamidronate showed a statistically significant antinociceptive action after i.v. and intramuscular administration. To verify if clodronate and pamidronate could modulate the peripheral opioid receptors we evaluated the gastrointestinal transit time in mice, but we did not find any effect on the gastrointestinal motility. These data indicate that clodronate and pamidronate present a central and peripheral antinociceptive effect; however, the main mechanism cannot be determined from the present data. We discuss the possible pharmacological hypothesis to interpret the present results. The findings suggest a pharmacological role of the bisphosphonates in the modulation of antinociception even in acute conditions not related to accelerated osteolytic and inflammatory response, with a possible clinical application to control pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275384     DOI: 10.1016/S0304-3959(00)00447-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

1.  Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice.

Authors:  Yasuhisa Abe; Kousuke Iba; Koichi Sasaki; Hironori Chiba; Kumiko Kanaya; Tomoyuki Kawamata; Kimimitsu Oda; Norio Amizuka; Muneteru Sasaki; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

2.  Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study.

Authors:  T Armingeat; R Brondino; T Pham; V Legré; P Lafforgue
Journal:  Osteoporos Int       Date:  2006-08-08       Impact factor: 4.507

3.  Anti-RANKL antibodies decrease CGRP expression in dorsal root ganglion neurons innervating injured lumbar intervertebral discs in rats.

Authors:  Masashi Sato; Kazuhide Inage; Yoshihiro Sakuma; Jun Sato; Sumihisa Orita; Kazuyo Yamauchi; Yawara Eguchi; Nobuyasu Ochiai; Kazuki Kuniyoshi; Yasuchika Aoki; Junichi Nakamura; Masayuki Miyagi; Miyako Suzuki; Gou Kubota; Takeshi Sainoh; Kazuki Fujimoto; Yasuhiro Shiga; Koki Abe; Hiroto Kanamoto; Gen Inoue; Kazuhisa Takahashi; Seiji Ohtori
Journal:  Eur Spine J       Date:  2015-06-14       Impact factor: 3.134

Review 4.  Pediatric Oncology: Managing Pain at the End of Life.

Authors:  Jennifer M Snaman; Justin N Baker; Jennifer H Ehrentraut; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

5.  Effective dosage and administration schedule of oral alendronate for non-nociceptive symptoms in rats with chronic constriction injury.

Authors:  Sun Im; Seong-Hoon Lim; Jong-In Lee; Young-Jin Ko; Joo Hyun Park; Bo-Young Hong; Geun-Young Park
Journal:  J Korean Med Sci       Date:  2010-05-25       Impact factor: 2.153

6.  The neurological safety of epidural pamidronate in rats.

Authors:  Pyung Bok Lee; Yong Chul Kim; Chul Joong Lee; Hye Young Shin; Seung Yun Lee; Jong Cook Park; Yun Suk Choi; Chong Soo Kim; Sang Hyun Park
Journal:  Korean J Pain       Date:  2010-05-31

Review 7.  Pamidronate treatment in rheumatology practice: a comprehensive review.

Authors:  Gleb Slobodin; Itzhak Rosner; Joy Feld; Doron Rimar; Michael Rozenbaum; Nina Boulman; Majed Odeh
Journal:  Clin Rheumatol       Date:  2009-08-19       Impact factor: 2.980

Review 8.  Clodronic acid formulations available in Europe and their use in osteoporosis: a review.

Authors:  Bruno Frediani; Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

9.  A pilot trial of intravenous pamidronate for chronic low back pain.

Authors:  Marco Pappagallo; Brenda Breuer; Hung-Mo Lin; James B Moberly; Julia Tai; Christopher Noto; Angela Sanchez; Paolo L Manfredi
Journal:  Pain       Date:  2013-09-21       Impact factor: 6.961

Review 10.  Clodronate: new directions of use.

Authors:  Bruno Frediani; Ilaria Bertoldi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.